Piper Sandler Maintains Overweight on Amplitude, Lowers Price Target to $21
Piper Sandler analyst Clarke Jeffries maintains Amplitude (NASDAQ:AMPL) with a Overweight and lowers the price target from $25 to $21.
SVB Leerink Maintains Underperform on Incyte, Raises Price Target to $63
SVB Leerink analyst Andrew Berens maintains Incyte (NASDAQ:INCY) with a Underperform and raises the price target from $58 to $63.
Raymond James Maintains Outperform on Murphy USA, Raises Price Target to $300
Raymond James analyst Bobby Griffin maintains Murphy USA (NYSE:MUSA) with a Outperform and raises the price target from $270 to $300.
Raymond James Remains Bullish On PACCAR, Cuts Price Target By ~10%
Raymond James analyst Felix Boeschen lowered the price target for PACCAR Inc (NASDAQ:PCAR) to $95 (an upside of 13%) from $105 while maintaining…
Raymond James Cuts Oshkosh’s Price Target By ~21%
Raymond James analyst Felix Boeschen lowered the price target for Oshkosh Corp (NYSE:OSK) to $95 (an upside of 12.5%) from $120 while maintaining…
Wells Fargo Slashes AMD’s Price Target By 7%: Find Out Why
Wells Fargo analyst Aaron Rakers maintained Advanced Micro Devices, Inc (NASDAQ:AMD) with an Overweight and cut the price target from $140 to $130.…
Raymond James Remains Bullish On Federal Signal, Cuts Price Target By ~7%
Raymond James analyst Felix Boeschen lowered the price target for Federal Signal Corp (NYSE:FSS) to $42 (an upside of 13.8%) from $45…
Key Takeaways From Wells Fargo’s Data Privacy Expert Discussion Regarding ZoomInfo
In light of recent lawsuits and short reports, which have placed ZoomInfo Technologies Inc’s (NASDAQ:ZI) data collection practices under greater…
RBC Capital Lowers Inovio Price Target As It Awaits This
RBC Capital Markets has lowered the price target on Inovio Pharmaceuticals Inc (NASDAQ:INO) to $4 from $5 with a Sector Perform rating.…
JMP Is Bullish On This Cancer Stock “Sees New Way to Treat Cancer”
JMP Securities has initiated the coverage on Aura Biosciences Inc (NASDAQ:AURA) with a Market Outperform rating and a $26 risk-adjusted price target. Aura…